| Description | GLPG3970 GLPG3970 is a novel orally available selective dual SIK2/SIK3 inhibitor.GLPG3970 has potential anti-inflammatory activity for the study of autoimmune diseases. |
| molecular weight | 504.5 |
| Molecular formula | C25H27F3N4O4 |
| CAS | 2403733-82-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 80 mg/mL (158.57 mM), Sonication is recommended. |
| References | 1. Peixoto C,et al. Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases. J Med Chem. 2024 Apr 11;67(7):5233-5258. |